Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, recently announced that the United States Food and Drug Administration (FDA) has ...

Europe certifies a new, more powerful space engine called the P160C. It is key to launching stronger rockets from South ...

The Korean diaspora has a complex relationship with the word "gyopo. " In the most literal sense, it refers to Koreans living ...

An all-out Sonic kart racer ready to rival the Italian plumber's own offering For a game that feels so heavily centred around ...

Apple Creator Studio is taking on Adobe's dominant Creative Cloud by offering a selection of apps to create content, paid ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...

South Asia’s strategic location, fragmented politics, and regional rivalries make it an ideal testing ground for the GSI’s ...

The German newspaper Die Welt reports that Chancellor Friedrich Merz is expected to make his first official visit to India in ...

Eisenstein's Battleship Potemkin is stronger than ever before, a century after its public premiere, thanks to its open source ...

Another strong InDesign alternative is VivaDesigner, which comes in both desktop and browser-based flavours and packs in ...